ACSQHC-ARCR-109

This is a prospective, multi-centre, observational, national registry of HCV infected patients.

The purpose of the registry is to establish a prospective national registry of patients with HCV liver disease attending ALA CRN liver clinics and hepatitis treatment centres, to better understand the epidemiology, treatment outcomes and health care burden and costs of the HCV pandemic.

The aims include:

• To describe the epidemiology of HCV infection in a prospective multicentre cohort of HCV infected patients
• To record baseline demographics, clinical, virologic and liver disease characteristics, and prior treatment status
• To characterise HCV treatment response and treatment limiting adverse event rates
• To assess the impact of treatment and virological response on patient outcomes
• To evaluate health care utilisation costs associated with chronic HCV infection.

The population includes: 

• Male and females ≥ 18 years of age.
• Under the care of an ALA CRN liver clinic or hepatitis treatment centre for management of hepatitis C infection.
• Evidence of current or prior HCV infection based on positive HCV RNA test by PCR.
• Written informed consent.